Status: current, Primitive. Date: 30-Sep 2020. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4453751000168111 | tafamidis meglumine (AU substance) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4453761000168113 | tafamidis meglumine | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| tafamidis meglumine | Is a | medicinal substance | true | Inferred relationship | Some | ||
| tafamidis meglumine | is modification of | tafamidis | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Vyndaqel 20 mg capsule | has Australian BoSS | True | tafamidis meglumine | Inferred relationship | Some | 1500685992 |
| tafamidis meglumine 20 mg capsule | has Australian BoSS | True | tafamidis meglumine | Inferred relationship | Some | 1425475300 |
This concept is not in any reference sets
FHIR